News
In terms of quality of life, someone 75 years old, retired with significant memory problems, can still have friends and, “a ...
15h
DPA International on MSNEMA recommends approval of additional Alzheimer's treatmentThe European Medicines Agency (EMA) cleared the way for the use of another drug to treat Alzheimer's disease on Friday.
As pharmaceutical companies struggle to develop Alzheimer’s treatments, scientists are searching for existing drugs that ...
Okanagan Clinical Trials is offering new opportunities for people to participate in important clinical research studies ...
A tiny flower-shaped particle could help to pave the way for a new treatment approach to Alzheimer's and Parkinson's that targets the root causes.
Li, Huang, and Sirota chose 2 cancer drugs out of the top 5 drug candidates for laboratory testing. They predicted one drug, ...
The AFA opens a new Alzheimer’s support center in Amityville, offering programs, memory screenings and caregiver respite for ...
2d
Medical Device Network on MSNAccelerating innovation in early Alzheimer’s disease diagnosisRoche is focusing on early diagnosis of Alzheimer's disease and will soon release its first blood-based biomarker for the ...
Individuals treated for breast cancer often develop cognitive issues, but they may have a lower risk for developing Alzheimer ...
Eli Lilly said on Friday that the European Medicines Agency (EMA) has recommended approval of its drug Kisunla for certain ...
1d
News Medical on MSNMath model sheds light on Alzheimer’s spreadMathematics may not be the first thing people associate with Alzheimer’s disease research. But for Pedro Maia, an assistant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results